Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Raghavendra Kumar Gunda"'
Publikováno v:
Turk J Pharm Sci
OBJECTIVES: The objective of the current study was to develop an extended release (XR) tablet formulation for ranolazine using Eudragit L 100-55 and hydroxypropylmethylcellulose (HPMC) K100M in an appropriate composition. Ranolazine, an anti-anginal
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 56:01-08
Publikováno v:
Turkish Journal of Pharmaceutical Sciences, Vol 17, Iss 2, Pp 221-227 (2020)
Turkish Journal of Pharmaceutical Sciences
Turkish Journal of Pharmaceutical Sciences
Objectives: The objective of the current study was to formulate a sustained release (SR) formulation for pravastatin. Pravastatin is a lipid lowering, biopharmaceutical classification class-III agent. Materials and Methods: SR tablets of pravastatin
Autor:
Penumula Ramanamma, Mariza Pires de Melo, Patrícia Goldschmidt Lins, Silvana Marina Piccoli Pugine, Yerra Sai Sumanjali, Tatikonda Nagendra Babu, Antonio Márcio Scatolini, Prasada Rao Manchineni, Somepalli Veeranjaneyulu, Satti Ravindra Kumar, Raghavendra Kumar Gunda
Publikováno v:
Journal of Analytical & Pharmaceutical Research. 9:60-66
Objective: The purpose of present investigation to formulate, characterize the oral dissolving tablets (ODT) for Lamotrigine. Lamotrigine, an antiepileptic agent, belongs to type –II as per Biopharmaceutical Classification System (BCS). Methods: OD
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 53:724-732
Publikováno v:
Journal of Pharmaceutics and Therapeutics. :238-247
Purpose: The main objective of present research investigation is to formulate the sustained release formulation of Rosuvastatin. Rosuvastatin, an antihyperlipidemic agent, belongs BCS class-II agent.Methods: The SR tablets of Rosuvastatin were prepar
Autor:
Prasada Rao Manchineni, Ekula Jyoshna, Kurapati Divya, Duddu Alekhya, Chaikam Gopi Reddy, Raghavendra Kumar Gunda
Publikováno v:
Journal of Analytical & Pharmaceutical Research. 8:85-89
Publikováno v:
International Journal of Advances in Pharmacy and Biotechnology. 4:13-24
Publikováno v:
Pharmaceutical Methods. 9:16-23
Publikováno v:
Pharmaceutical Methods. 8:160-167